DRKS00030593招募中不适用
Posttherapeutic biomarker expression in mCRC patients with liver metastasis”The PRO-MARKER observational study - PRO-MARKER
MU München0 个研究点目标入组 100 人开始时间: 2023年7月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Histologically proven mCRC
- •Patients with liver dominant metastatic CRC
- •Inclusion after full resection or local ablation of liver metastases
- •ECOG 0-2
- •Limited extrahepatic metastases
排除标准
- •Life expectancy =3 months
- •Known liver cirrhosis
研究者
相似试验
招募中
不适用
Organoids to Predict Treatment response In mCRC (OPTIC)colorectal carcinoma10017991colorectal cancerNL-OMON54759MC Utrecht193
招募中
不适用
Determination of new biomarkers in patients with resectable colorectal liver metastases, the MIRACLE studycolorectal liver metastases10027476NL-OMON50622Erasmus MC, Universitair Medisch Centrum Rotterdam240
招募中
不适用
The MIRACLE studyNL-OMON21289Prof. Dr. C. Verhoef Erasmus, Head of department of Surgical Oncology, MC Cancer Institute Groene Hilledijk 301, 3075 EA, Rotterdam240
已完成
不适用
MRI based prognostic biomarkers for treatment success of Minimal invasive treatment for Uterine Fibroids with Magnetic Resonance guided High Intensity Focused Ultrasound (MR-HIFU)leiomyomauterine fibroid10046828NL-OMON46077Isala Klinieken75
招募中
不适用
Het gebruik van organoiden om de respons op chemotherapie bij darmkanker patiënten te voorspellen.NL-OMON20088MC UtrechtDept. of Medical OncologyUMC UtrechtPO Box 85500 (Q04.4.300), 3508 GA Utrecht, the Netherlands150